Health

Results: 397-408 of 10101

Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)

PR Newswire associated0

2026 Tang Prize Award Ceremony Honors Six Laureates

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis

THE 'SOBER CURIOUS' GENERATION: WHY FEWER DRINKERS DOESN'T MEAN LESS HARM, SAYS CASTLE CRAIG"

Stephan Eder, CEO, Pharmanovia

IMPACT Therapeutics and Pharmanovia Announce Positive CHMP Opinion for Senaparib, as a Potential First-Line Maintenance Treatment of Advanced High-Grade Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

PR Newswire associated0

mAbxience and Sandoz Sign a Collaboration Agreement to Advance Biosimilar Access Worldwide

ACROBiosystems deepens its France presence with a dedicated hub at The HIVE Innovation Center, embedding into the Campus Grand Parc ecosystem

Takeda Employees Select Four New Global Corporate Social Responsibility Collaborations to Advance Climate-Resilient Health Systems

Medisca Launches Global Peptide Division

PR Newswire associated0

New Peer-Reviewed Study Confirms Innovative Technology Shatters ESR's Four-Hour Deadline

AMRA Medical Earns TIME’s Highest “Outstanding” Rating in World’s Top HealthTech Companies 2026